Fabrication of Chitosan/Graphene Oxide/PVA-Vanillin@TiO₂ Composites for Anti-Inflammatory Drug Removal from...

In this work, three functionalized hybrid composites, CS/PVA-VAN, CS/PVA-VAN@TiO₂ and CS/GO/PVA-VAN@TiO₂, were synthesized and applied for adsorption evaluation on two common non-steroidal anti-inflammatory drugs, i.e., diclofenac (DCF) and ketoprofen (KTP). The structural and morphological characteristics of new composites were identified via Fourier-transform infrared spectroscopy (FTIR), scanning electron microscopy (SEM), X-ray diffraction (XRD) and BET techniques. BET analysis demonstrated that the CS/GO/PVA-Van@TiO₂ composite has a surface area 64.86 m²/g, which is twice that of CS/PVA-Van. Moreover, adsorption evaluation was achieved at an optimum pH condition (pH 5.0) for both drugs. In addition, the kinetic data fitted better in a pseudo-second-order kinetic model, while the adsorption was heterogeneous and multilayer. The adsorption capacity of CS/GO/PVA-VAN@TiO₂ was found to be 114.53 mg/g and 65.20 mg/g for diclofenac and ketoprofen, respectively. Thermodynamic analysis confirmed that the adsorption process was endothermic and spontaneous for all pollutants. Moreover, the kinetic swelling and stability studies demonstrated that graphene oxide contributed to improving the structural compactness and stability of composite. Finally, the adsorption performance of the optimal composite material was investigated in a binary system of non-steroidal anti-inflammatory drugs in various ratios.